TRVI — Trevi Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Trevi Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36.8	121	83	108	188
Net Total Receivables	—	—	—	0.532	0.986
Prepaid Expenses
Total Other Current Assets
Total Current Assets	38	123	87.5	109	192
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.184	0.194	1.56	1.23	0.855
Other Long Term Assets
Total Assets	38.5	123	89.4	111	193
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	12.7	13.4	5.82	10.5	9.75
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.4	15.6	6.86	11.3	10.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.1	107	82.5	99.6	183
Total Liabilities & Shareholders' Equity	38.5	123	89.4	111	193
Total Common Shares Outstanding